Estimating bisphosphonate use and fractu
โ
Ethel S Siris; Margaret K Pasquale; Yiting Wang; Nelson B Watts
๐
Article
๐
2010
๐
American Society for Bone and Mineral Research
๐
English
โ 242 KB
Oral bisphosphonates are first-line therapy for the prevention and treatment of osteoporosis in postmenopausal women. Although bisphosphonate treatment has been shown to reduce fractures in randomized, controlled trials, the number of women treated and fractures prevented over the years have not bee